Skip to main content
. 2020 Sep 8;103(5):2029–2039. doi: 10.4269/ajtmh.19-0855

Table 3.

Estimated number of dengue cases, aggregate economic burden, and cost per episode in Indonesia by outcome and setting in 2017

Nonfatal cases Fatal cases
Location Hospitalized Ambulatory Not medically attended Children Adults Total
Estimated number of cases
 National 963,894 (182,172–2,034,019) 1,720,254 (26,229–3,949,950) 4,847,450 (1,108,670–10,520,849) 1,317 (572–2,966) 2,340 (1,016–5,270) 7,535,256 (1,318,658–16,513,055)
 Yogyakarta city 3,908 (686–12,886) 7,195 (0–27,319) 10,332 (2,186–36,220) 4 (1–14) 8 (2–25) 21,447 (3,416–76,005)
Estimated aggregate economic burden of dengue (US$ millions)
 National 304.82 (89.12–1,042.56) 38.61 (3.05–488.32) 36.25 (8.91–147.44) 139.95 (60.88–321.71) 161.63 (70.31–371.53) 681.26 (232.28–2,371.56)
 Yogyakarta city 1.24 (0.28–5.46) 0.16 (0.00–27.09) 0.08 (0.02–0.40) 0.46 (0.13–1.58) 0.53 (0.15–1.82) 2.46 (0.58–36.35)
Estimated cost per episode (US$)
 National 316.24 (242.30–390.18) 22.45 (14.12–30.77) 7.48 (2.36–12.60) 106,247.41 (98,374.05–125,622.30) 69,060.81 (63,943.13–81,654.49) 90.41 (72.79–112.35)

Costs of nonfatal cases were derived as explained in notes to Table 2. Costs per episode of fatal cases were adjusted from those reported by Shepard et al.1 using the change in Indonesia’s per capita gross national income. Numbers in parentheses are 95% uncertainty intervals.